stoxline Quote Chart Rank Option Currency Glossary
  
Ginkgo Bioworks Holdings, Inc. (DNA)
14.73  1.18 (8.71%)    02-14 16:00
Open: 14
High: 15.33
Volume: 2,865,407
  
Pre. Close: 13.55
Low: 13.94
Market Cap: 847(M)
Technical analysis
2025-02-14 4:47:29 PM
Short term     
Mid term     
Targets 6-month :  19.68 1-year :  22.98
Resists First :  16.85 Second :  19.68
Pivot price 13.59
Supports First :  11.65 Second :  8.43
MAs MA(5) :  13.3 MA(20) :  13.31
MA(100) :  9.67 MA(250) :  19.28
MACD MACD :  0.7 Signal :  0.8
%K %D K(14,3) :  41.1 D(3) :  31.2
RSI RSI(14): 59.3
52-week High :  64.4 Low :  5.26
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ DNA ] has closed below upper band by 23.9%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 15.36 - 15.43 15.43 - 15.5
Low: 13.77 - 13.85 13.85 - 13.92
Close: 14.59 - 14.73 14.73 - 14.85
Company Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Headline News

Sat, 15 Feb 2025
Ginkgo Bioworks (NYSE:DNA) Trading 8.8% Higher - Here's Why - MarketBeat

Sat, 15 Feb 2025
Ginkgo Bioworks (NYSE:DNA) Shares Down 5.4% - Here's Why - MarketBeat

Thu, 13 Feb 2025
Revenues Not Telling The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) After Shares Rise 39% - Simply Wall St

Wed, 12 Feb 2025
Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know - Nasdaq

Wed, 12 Feb 2025
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Forbes J M & Co. LLP - MarketBeat

Thu, 06 Feb 2025
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series - Quantisnow

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 45 (M)
Shares Float 33 (M)
Held by Insiders 6.6 (%)
Held by Institutions 68.8 (%)
Shares Short 7,830 (K)
Shares Short P.Month 7,170 (K)
Stock Financials
EPS -12.9
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 14.64
Profit Margin -298.8 %
Operating Margin -58.7 %
Return on Assets (ttm) -21 %
Return on Equity (ttm) -63.6 %
Qtrly Rev. Growth 60.5 %
Gross Profit (p.s.) 3.9
Sales Per Share 4.82
EBITDA (p.s.) -11.64
Qtrly Earnings Growth 0 %
Operating Cash Flow -335 (M)
Levered Free Cash Flow -317 (M)
Stock Valuations
PE Ratio -1.15
PEG Ratio 0
Price to Book value 1
Price to Sales 3.05
Price to Cash Flow -1.99
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android